Review Article
Published: 17 March, 2021 | Volume 5 - Issue 1 | Pages: 002-005
Cervical cancer constitutes an issue in public health, becoming the leading cause of death by cancer in women between 20-40 years of age in Latin America. In Argentina 5000 new cases are diagnosed each year, where more than 56% are in advanced stages. The aim of the present current opinion or critical review article is to remark the importance of the prognostic significance of the Central Tumor Size in stages IIB and IIIB cervical cancer, as well as to propose a new FIGO Staging System for Cervical cancer and trying to find out a role for the different therapeutic strategies for those cases.
Read Full Article HTML DOI: 10.29328/journal.acst.1001023 Cite this Article Read Full Article PDF
Cervical cancer; Central tumor size; FIGO staging system; Neoadjuvant chemotherapy; Oncological treatments
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."